There were 21 deaths in patients assigned to control compared to thirteen assigned to colchicine. Conclusion Long-term prophylaxis with low-dose colchicine appears safe and may be effective for a ...

Objectives We conducted an updated systematic review and meta-analysis to investigate the effect of colchicine treatment on clinical outcomes in patients with COVID-19. Data sources We searched PubMed ...

Acute MI survivors have increased risk of further events, due to inflammation. Data on colchicine, an established anti-inflammatory, suggests a reduction in cardiovascular events by inflammatory ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Background Recommended colchicine dose in familial mediterranean fever (FMF) is 1–1.5 mg/day in adults. If necessary it can be increased up to 3 mg/day by clinical monitoring. In the final FMF ...

Treatment with colchicine 0.5 mg 8-hourly resulted in rapid clinical resolution. This case report highlights how cardiac injury can dominate the clinical picture in COVID-19 infection. The role of ...

Among patients with stable coronary artery disease, colchicine lowered total plaque volume compared with placebo but had no ...

The second point is related to the therapeutic approach. Our experience shows that increasing the colchicine dose during the perimenstrual period or the use of contraceptives when indicated, may ...